搜索结果31-40 的 858 / ���������������������������op������r���:za33���
The purpose of this study is to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive ...
Rochester, Minn. The purpose of this study is to develop prognostic and diagnostic blood tests for symptomatic brain hemorrhage in patients diagnosed with ...
Rochester, Minn., Jacksonville, Fla. The purpose of this study is to evaluate the effects of ibrutinib and rituximab with or without venetoclax in treating ...
Our AYA Cancer Program provides comprehensive, tailored to people ages 15 to 39 facing the challenges of cancer and addresses the unique needs of each ...
妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一，在亚利桑那州、佛罗里达州和明尼苏达州都有院区。医务人员掌握几十种专业技能，齐心协力，确保高品质治疗与成功 ...
... (R/M) squamous cell carcinoma of the head and neck (SCCHN). A Feasibility ... (r/r B-ALL). Pagination 临床研究. PrevPrevious Page · Go to page 5151 · Go to page ...
The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's transformation, ...
The purose of this study is to evaluate the effiectiveness, safety, and pharmacokinetics of tirabrutinib monotherapy in patients with relapsed or refractory ...
Rochester, Minn. The registry aims to collect patient information such as patient demographics, co-morbidities, clinical, diagnostic, and therapeutic data, as ...
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护，共同推动医学的改变。